Ascorbic acid suppresses the 2,3,7,8-tetrachloridibenxo-p-dioxin (TCDD)-induced CYP1A1 expression in human HepG2

Hee J Chang1, Jung S Park, Eun K Lee

  • 1The Brain Korea 21 Project, Center for Biomedical Human Resources at Chonnam National University, Department of Biochemistry, Chonnam National University Medical School, 5 Hakdong, Gwangju 501-190, Republic of Korea.

Insights

Ascorbic acid (AA) inhibits carcinogenesis by suppressing the aryl hydrocarbon receptor (AhR) and its target gene, cytochrome P4501A1 (CYP1A1). This mechanism, distinct from free-radical scavenging, offers new insights into cancer prevention strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • The exact mechanisms of ascorbic acid (AA) in preventing cancer are not fully understood, beyond its known antioxidant properties.
  • Ascorbic acid's role in modulating the aryl hydrocarbon receptor (AhR) pathway, which influences the expression of genes involved in carcinogenesis, requires further investigation.

Purpose of the Study:

  • To investigate the inhibitory effects of ascorbic acid (AA) on the expression of the AhR-regulated gene cytochrome P4501A1 (CYP1A1).
  • To elucidate the molecular mechanisms by which AA influences CYP1A1 gene expression and its potential role in anticarcinogenesis.

Main Methods:

  • Human HepG2 cells were treated with ascorbic acid (AA) and/or 2,3,7,8-tetrachloridibenzo-p-dioxin (TCDD), a potent AhR agonist.
  • Quantitative analysis of CYP1A1 mRNA and protein levels, 7-ethoxyresorufin O-deethylase (EROD) activity, and Ecto-ATPase activity.
  • Transient transfection assays with a dioxin response element (DRE)-linked luciferase reporter and electrophoretic mobility shift assays (EMSA) were performed.

Main Results:

  • Ascorbic acid (AA) significantly suppressed TCDD-induced CYP1A1 gene and protein expression, as well as CYP1A1-specific EROD activity.
  • AA reduced the binding of the aryl hydrocarbon receptor (AhR) to the DRE sequence in the CYP1A1 promoter region.
  • AA inhibited TCDD-induced Ecto-ATPase activity, a process crucial for AhR nuclear translocation.

Conclusions:

  • Ascorbic acid (AA) exerts anticarcinogenic effects, at least partly, by inhibiting CYP1A1 expression at the transcriptional level.
  • AA interferes with the aryl hydrocarbon receptor (AhR) pathway, specifically hindering AhR binding to the CYP1A1 gene promoter.
  • These findings reveal a novel mechanism for AA's chemopreventive potential, independent of its free-radical scavenging activity.

Related Concept Videos